| Document Date: 2009-04-28 14:40:33
Open Document File Size: 65,87 KBShare Result on Facebook
City Deerfield / / Company Aventis / Abbott Pharmaceuticals PR Ltd. / Sanofi / Lundbeck Inc. / / Country United States / / Currency AED / / Event Product Issues / Product Recall / / IndustryTerm dangerous machinery / Aqueous solutions / healthcare providers / / MedicalCondition convulsive seizures / Generally milder withdrawal symptoms / partial seizures / ataxia / genitourinary complaints / CNS depression / headache / severe withdrawal symptoms / coma / Depressive Neuroses / tremor / drug dependence / fatigue / drowsiness / hypersensitivity / diarrhea / muscle cramps / Deep coma / illness / Hypotension / ataxia / insomnia / anxiety disorders / acute narrow angle glaucoma / seizure / vomiting / concomitant disease / muscle aches / respiratory depression / delirium / epilepsy / dizziness / Withdrawal symptoms / depression / diplopia / cholestasis / somatic disease / syndrome / untreated illness / / MedicalTreatment adjunctive therapy / drug therapy / / Organization Prolonged administration / PRECAUTIONS / DOSAGE AND ADMINISTRATION / / / Position physician / / Product potassium chloride / TAB Tablets / TRANXENE / CONTRAINDICATIONS TRANXENE / meprobamate / alcohol / Ideation Antiepileptic / T-TAB® Tablets / clorazepate dipotassium / T-TAB tablets / diazepam / norepinephrine bitartrate / metaraminol bitartrate / oxazepam / talc / Flumazenil / T-TAB tablet / occupations / / ProvinceOrState Illinois / / URL http /
SocialTag |
TRANXENE* T-TAB® Tablets clorazepate dipotassium tablets, USP Rx only DESCRIPTION Chemically, TRANXENE is a benzodiazepine. The empirical formula is C16H11ClK2N2O4; the molecular weight is[removed]; 1H-1, 4-Benzodiazepine